PubMed=9384677
Brigitte Guckel, Markus Lindauer, Wolfgang Rudy, Annette Habicht, Michael Siebels, Sepp Kaul, Gunther Bastert, Stefan Carl Meuer, Ulrich Moebius;
CD80-transfected human breast and ovarian tumor cell lines: improved immunogenicity and induction of cytolytic CD8+ T lymphocytes.
Cytokines Mol. Ther. 1:211-221(1995)

PubMed=10359208; DOI=10.1038/sj.cgt.7700050
Brigitte Guckel, Geeske C. Meyer, Wolfgang Rudy, Richard Batrla, Stefan Carl Meuer, Gunther Bastert, Diethelm Wallwiener, Ulrich Moebius;
Interleukin-12 requires initial CD80-mediated T-cell activation to support immune responses toward human breast and ovarian carcinoma.
Cancer Gene Ther. 6:228-237(1999)

PubMed=10359214; DOI=10.1038/sj.cgt.7700054
Geeske C. Meyer, Richard Batrla, Wolfgang Rudy, Stefan Carl Meuer, Diethelm Wallwiener, Brigitte Guckel, Ulrich Moebius;
Potential of CD80-transfected human breast carcinoma cells to induce peptide-specific T lymphocytes in an allogeneic human histocompatibility leukocyte antigens (HLA)-A2.1+-matched situation.
Cancer Gene Ther. 6:282-288(1999)

PubMed=15365776; DOI=10.1007/s00262-004-0583-z; PMCID=PMC11034349
Brigitte Guckel, Susanne Stumm, Christine Rentzsch, Alexander Marme, Geeske Mannhardt, Diethelm Wallwiener;
A CD80-transfected human breast cancer cell variant induces HER-2/neu-specific T cells in HLA-A*02-matched situations in vitro as well as in vivo.
Cancer Immunol. Immunother. 54:129-140(2005)